Nanotech Wire News:

MagForce Nanotechnologies rises 0.2% on low volume for a third consecutive day, a three day rise of 1.2%

News Bites - Western Europe : Germany
February 18, 2011

MagForce Nanotechnologies (MF6.F) rose 5.0c (or 0.2%) for a third consecutive day on Friday bringing its three-day rise to 35.0c or1.2%. Compared with the DAX index, which rose 21.3 points (or 0.3%) on the day, this was a relative price change of -0.1%.


Volatility: the stock traded between an intraday low of EUR29.625 and a high of EUR30.17, suggesting a trading opportunity between peaks and troughs.

Moving average price (MAP) [with equal weightage to prices at close]: the price to 200-day MAP ratio is 0.9, a bearish indicator. In the past 200 days this ratio has been under 0.9 120 times suggesting further downside. The 50-day MAP of EUR25.818 is lower than the 200-day MAP of EUR33.516, a bearish indicator. The 200-day MAP has decreased to EUR33.516. A decrease is another bearish indicator.

Exponential Moving Average Price (EMAP) [with higher weightage to recent prices]: the price to 50-day EMAP ratio is 1.1, a bullish indicator. In the past 50 days this ratio has exceeded 1.1 16 times suggesting further upside. The 50-day EMAP has increased to EUR27.982. An increase is another bullish indicator.

Moving Average Convergence Divergence (MACD): the MACD indicator of 12-day Exponential Moving Average (EMA) minus the 26-day EMA is positive suggesting a bullish signal.

Relativities: today its percentile rank in the German market was 57. In the German market of 1,162 stocks traded today, the stock has a 6-month relative strength of 7 indicating it is trailing 93.0% of the market.

% Discount to high: the last price is at a discount of 38.3% to the 12-month high of EUR48.90 eight months ago on 28 Jun, 2010.

Volume weighted price (VWP): the price is about the same as its 1-month volume weighted average price of EUR30.766.

Oversold [Bullish Signals]: the Stochastic indicator of 16.8 has broken through the oversold line of 20; the stock is also oversold according to the Williams % R indicator of -81.7.


[Volume Index or VI in brackets; 1 is average]

Frankfurt: MF6.F 379 [VI of 0.3]; volume 71.78% of aggregate. Price: EUR30.15.

Xetra: MF6.DE 149 [VI of 0.1]; volume 28.22% of aggregate. Price: EUR30.295. Using the current exchange rate of EUR1 equals 1.0EUR, the shares are at a 0.5% premium to the close price in the German Stock Exchange.

Aggregate volume: there were 528 shares worth EUR15,941 (US$21,727.6) traded. The aggregate volume was 0.1 times average trading of 5,536 shares.

Access comprehensive Stock Research on


The stock is in 2 sectors.

The following index and sector rose setting the trend for its rise of 0.2%:

DAX index which was up 21.3 points or 0.3% to 7,426.8,

Chemicals sector of 40 stocks traded today, which was up 9.8 points or 0.2% to 6,248.7

The stock's rise went against the trend set by the Total German Market of 1162 stocks traded today, which was down 1.0 points or 0.02% to 6,172.6


Trailing one week: the stock rose three times (60% of the time) and fell twice (40% of the time). The aggregate volume was 0.4 times average trading of 13,965 shares. The value of EUR1,000 invested a week ago is EUR982 [vs EUR1,008 for the DAX index], for a capital loss of EUR18(or loss of 1.8%).

Trailing one month: the stock rose eleven times (48% of the time), fell ten times (43% of the time) and was untraded twice (9% of the time). The aggregate volume was 2.3 times average trading of 61,446 shares. The value of EUR1,000 invested a month ago is EUR1,138 [vs EUR1,040 for the DAX index], for a capital gain of EUR138(or rise of 13.8%).

Trailing one year: the value of EUR1,000 invested one year ago is EUR718 [vs EUR1,334 for the DAX index], for a capital loss of EUR282. The total return to shareholders for 1 year is -28.2%.

Trailing five years: the value of EUR1,000 invested five years ago is EUR1,325, for a capital gain of EUR325.


Based on 3,856,190 issued equity shares the market capitalisation is EUR116.3 million (US$158.5 million).


Magforce Nanotechnologies AG develops medical technologies. It specializes in nanocancer therapy for treatment of cancerous tumors.


The chief executive officer is Uwe Maschek.


The last 5 company announcements are:

November 18: MagForce Nanotechnologies AG prasentiert auf dem Deutschen Eigenkapitalforum

[Company Releases] Source: Company Website

November 17: MagForce Selected as Winner of 2010 STEP Award in the Category Product/Technology

* Prize awarded in recognition of company's innovation and growth potentialBerlin, November 17, 2010 - MagForce Nanotechnologies AG (FSE:MF6), a leader in the area of nanotechnology-based cancer treatment, announced today that it has been selected as the 2010 recipient of the STEP award in the category product/technology.

June 28: MagForce Nanotechnologies AG received European approval for the Nano-Cancer therapy

Berlin - established in 1997 MagForce Nanotechnologies AG received after years of intensive research and development, the European approval for its Nano-Cancer (Registered) therapy. The admission means that the tested notified bodies which are responsible for the conformity assessment of medical devices, their examination of the marketing approval application form for the Nano-Cancer (Registered) therapy have been completed and has met the treatment all the requirements in terms of quality, safety and efficacy.

June 22: MagForce Nanotechnologies AG successfully completes share placement

Announcement in accordance with section 17 para. 2 of the General Terms and Conditions of Deutsche Borse AG for the Regulated Unofficial Market on the Frankfurt Stock ExchangeBerlin - MagForce Nanotechnologies AG, a medical technology company listed in the Entry Standard segment of the Frankfurt Stock Exchange, completed a placement of equity with German and international institutional investors.

December 10, 2009: MagForce Nanotechnologies announces change in supervisory board

MagForce Nanotechnologies has announced that Professor Wolfgang Heckl has been newly appointed as member of its supervisory board, following the election of Dr. Peter Heinrich, until now deputy chairman of the supervisory board, as the new CEO of Company effective January 1, 2010.

Currency Conversion: Euro1= US$1.363 [or US$1=Euro0.73]; Against the US$ the Euro increased 28.7 basis points (or 0.3%) for the day; increased 0.7% for the week; dipped 0.4% for the month; jumped 12.5% in the past year. EUR1 = 100c.


Copyright 2011 News Bites Pty Ltd.All Rights Reserved
News Bites - Western Europe : Germany

Wire News provided by

Lexis Nexis

Small Times Article Categories:

Nanotech Life Sciences and Medical
MEMS Tools and Equipment
Materials Wire News
Energy and Environment Small Times Magazine Current Issue
Research and Development Small Times Archives